BDO Wealth Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

BDO Wealth Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-14	Closed	-$3K	–	1147
2021 Q4	$3K	Hold	14	–	–	﹤0.01%	920
2021 Q3	$3K	Hold	14	–	–	﹤0.01%	925
2021 Q2	$3K	Hold	14	–	–	﹤0.01%	963
2021 Q1	$3K	Hold	14	–	–	﹤0.01%	960
2020 Q4	$3K	Sell	14 -15	-52%	-$3.44K	﹤0.01%	737
2020 Q3	$8K	Buy	29 +15	+107%	+$4.14K	﹤0.01%	512
2020 Q2	$4K	Hold	14	–	–	﹤0.01%	584
2020 Q1	$3K	Buy	+14	New	+$3.21K	﹤0.01%	657
2018 Q4	–	Sell	-450	Closed	-$87K	–	630
2018 Q3	$87K	Buy	+450	New	+$80.1K	0.03%	229

Other funds holding VRTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BDO Wealth Advisors's VRTX Position: Q1 2022 in Review

BDO Wealth Advisors sold out of Vertex Pharmaceuticals (VRTX) in Q1 2022, closing a stake of 14 shares — an estimated $3K sold.

BDO Wealth Advisors first reported a position in VRTX in Q3 2018 and held it in 9 quarters. The position peaked at $87K in Q3 2018. 1,071 funds tracked by Wall St. Rank hold VRTX as of Q1 2022.

BDO Wealth Advisors reported no remaining Vertex Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
BDO Wealth Advisors sold 14 Vertex Pharmaceuticals shares in Q1 2022, an estimated $3K.
BDO Wealth Advisors first reported a position in Vertex Pharmaceuticals in Q3 2018 and held it in 9 quarters.
BDO Wealth Advisors's Vertex Pharmaceuticals position peaked at $87K in Q3 2018.
1,071 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2022.

Based on BDO Wealth Advisors's 13F filing for Q1 2022, filed 6 May 2022.